243 related articles for article (PubMed ID: 38344249)
1. No additional risk of congenital anomalies after first-trimester dydrogesterone use: a systematic review and meta-analysis.
Katalinic A; Noftz MR; Garcia-Velasco JA; Shulman LP; van den Anker JN; Strauss Iii JF
Hum Reprod Open; 2024; 2024(1):hoae004. PubMed ID: 38344249
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Evidence-based guideline: unexplained infertility†.
; Romualdi D; Ata B; Bhattacharya S; Bosch E; Costello M; Gersak K; Homburg R; Mincheva M; Norman RJ; Piltonen T; Dos Santos-Ribeiro S; Scicluna D; Somers S; Sunkara SK; Verhoeve HR; Le Clef N
Hum Reprod; 2023 Oct; 38(10):1881-1890. PubMed ID: 37599566
[TBL] [Abstract][Full Text] [Related]
4. ESHRE guideline: number of embryos to transfer during IVF/ICSI†.
; Alteri A; Arroyo G; Baccino G; Craciunas L; De Geyter C; Ebner T; Koleva M; Kordic K; Mcheik S; Mertes H; Pavicic Baldani D; Rodriguez-Wallberg KA; Rugescu I; Santos-Ribeiro S; Tilleman K; Woodward B; Vermeulen N; Veleva Z
Hum Reprod; 2024 Apr; 39(4):647-657. PubMed ID: 38364208
[TBL] [Abstract][Full Text] [Related]
5. Elective freezing of embryos versus fresh embryo transfer in IVF: a multicentre randomized controlled trial in the UK (E-Freeze).
Maheshwari A; Bell JL; Bhide P; Brison D; Child T; Chong HY; Cheong Y; Cole C; Coomarasamy A; Cutting R; Hardy P; Hamoda H; Juszczak E; Khalaf Y; Kurinczuk JJ; Lavery S; Linsell L; Macklon N; Mathur R; Pundir J; Raine-Fenning N; Rajkohwa M; Scotland G; Stanbury K; Troup S; Bhattacharya S
Hum Reprod; 2022 Mar; 37(3):476-487. PubMed ID: 34999830
[TBL] [Abstract][Full Text] [Related]
6. ESHRE guideline: endometriosis.
Becker CM; Bokor A; Heikinheimo O; Horne A; Jansen F; Kiesel L; King K; Kvaskoff M; Nap A; Petersen K; Saridogan E; Tomassetti C; van Hanegem N; Vulliemoz N; Vermeulen N;
Hum Reprod Open; 2022; 2022(2):hoac009. PubMed ID: 35350465
[TBL] [Abstract][Full Text] [Related]
7. The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF.
Massin N; Abdennebi I; Porcu-Buisson G; Chevalier N; Descat E; Piétin-Vialle C; Goro S; Brussieux M; Pinto M; Pasquier M; Bry-Gauillard H
Hum Reprod; 2023 May; 38(5):927-937. PubMed ID: 36864699
[TBL] [Abstract][Full Text] [Related]
8. Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial.
Griesinger G; Blockeel C; Sukhikh GT; Patki A; Dhorepatil B; Yang DZ; Chen ZJ; Kahler E; Pexman-Fieth C; Tournaye H
Hum Reprod; 2018 Dec; 33(12):2212-2221. PubMed ID: 30304457
[TBL] [Abstract][Full Text] [Related]
9. Oral dydrogesterone versus micronized vaginal progesterone for luteal phase support: a double-blind crossover study investigating pharmacokinetics and impact on the endometrium.
Loreti S; Thiele K; De Brucker M; Olsen C; Centelles-Lodeiro J; Bourgain C; Waelput W; Tournaye H; Griesinger G; Raes J; Vieira-Silva S; Arck P; Blockeel C; Mackens S
Hum Reprod; 2024 Feb; 39(2):403-412. PubMed ID: 38110714
[TBL] [Abstract][Full Text] [Related]
10. ESHRE guideline: ovarian stimulation for IVF/ICSI
Ovarian Stimulation TEGGO; Bosch E; Broer S; Griesinger G; Grynberg M; Humaidan P; Kolibianakis E; Kunicki M; La Marca A; Lainas G; Le Clef N; Massin N; Mastenbroek S; Polyzos N; Sunkara SK; Timeva T; Töyli M; Urbancsek J; Vermeulen N; Broekmans F
Hum Reprod Open; 2020; 2020(2):hoaa009. PubMed ID: 32395637
[TBL] [Abstract][Full Text] [Related]
11. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study.
Koedooder R; Singer M; Schoenmakers S; Savelkoul PHM; Morré SA; de Jonge JD; Poort L; Cuypers WJSS; Beckers NGM; Broekmans FJM; Cohlen BJ; den Hartog JE; Fleischer K; Lambalk CB; Smeenk JMJS; Budding AE; Laven JSE
Hum Reprod; 2019 Jun; 34(6):1042-1054. PubMed ID: 31119299
[TBL] [Abstract][Full Text] [Related]
12. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
Teede HJ; Tay CT; Laven JJE; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE
J Clin Endocrinol Metab; 2023 Sep; 108(10):2447-2469. PubMed ID: 37580314
[TBL] [Abstract][Full Text] [Related]
13. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
Teede HJ; Tay CT; Laven J; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; M Redman L; A Boyle J; Norman RJ; Mousa A; Joham AE;
Fertil Steril; 2023 Oct; 120(4):767-793. PubMed ID: 37589624
[TBL] [Abstract][Full Text] [Related]
14. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome†.
Teede HJ; Tay CT; Laven J; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE;
Hum Reprod; 2023 Sep; 38(9):1655-1679. PubMed ID: 37580037
[TBL] [Abstract][Full Text] [Related]
15. Dydrogesterone and 20α-dihydrodydrogesterone plasma levels on day of embryo transfer and clinical outcome in an anovulatory programmed frozen-thawed embryo transfer cycle: a prospective cohort study.
Neumann K; Masuch A; Vonthein R; Depenbusch M; Schultze-Mosgau A; Eggersmann TK; Griesinger G
Hum Reprod; 2022 May; 37(6):1183-1193. PubMed ID: 35323905
[TBL] [Abstract][Full Text] [Related]
16. Current global status of male reproductive health.
De Jonge CJ; Barratt CLR; Aitken RJ; Anderson RA; Baker P; Chan DYL; Connolly MP; Eisenberg ML; Garrido N; Jørgensen N; Kimmins S; Krausz C; McLachlan RI; Niederberger C; O'Bryan MK; Pacey A; Priskorn L; Rautakallio-Hokkanen S; Serour G; Veltman JA; Vogel DL; Vazquez-Levin MH
Hum Reprod Open; 2024; 2024(2):hoae017. PubMed ID: 38699533
[TBL] [Abstract][Full Text] [Related]
17. Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3).
Donnez J; Becker C; Taylor H; Carmona Herrera F; Donnez O; Horne A; Paszkowski M; Petraglia F; Renner SP; Patel A; Boolell M; Bestel E; Dolmans MM
Hum Reprod; 2024 Apr; ():. PubMed ID: 38648863
[TBL] [Abstract][Full Text] [Related]
18. BEYOND: a randomized controlled trial comparing efficacy and safety of individualized follitropin delta dosing in a GnRH agonist versus antagonist protocol during the first ovarian stimulation cycle.
Lobo R; Soerdal T; Ekerhovd E; Cohlen B; Porcu E; Schenk M; Shufaro Y; Smeenk J; Suerdieck MB; Pinton P; Pinborg A;
Hum Reprod; 2024 May; ():. PubMed ID: 38723189
[TBL] [Abstract][Full Text] [Related]
19. Good practice recommendations on add-ons in reproductive medicine†.
; Lundin K; Bentzen JG; Bozdag G; Ebner T; Harper J; Le Clef N; Moffett A; Norcross S; Polyzos NP; Rautakallio-Hokkanen S; Sfontouris I; Sermon K; Vermeulen N; Pinborg A
Hum Reprod; 2023 Nov; 38(11):2062-2104. PubMed ID: 37747409
[TBL] [Abstract][Full Text] [Related]
20. Progestogens for preventing miscarriage: a network meta-analysis.
Devall AJ; Papadopoulou A; Podesek M; Haas DM; Price MJ; Coomarasamy A; Gallos ID
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013792. PubMed ID: 33872382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
